secwatch.observer — SEC 8-K summary
======================================

Issuer:     Immunome Inc. (IMNM)
CIK:        0001472012
Form:       8-K
Filed at:   2023-07-05T23:59:59+00:00
Accession:  0001104659-23-078220
Event type: other
Sentiment:  neutral
Materiality: 0.30
Item codes: 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Immunome posts updated investor presentation suggesting combination with Morphimmune; no deal terms disclosed
--------------------------------------------------------------------------------

- On July 5, 2023, Immunome filed Form 8-K announcing posting of an updated investor presentation on its website.
- Presentation is titled 'Morphimmune and Immunome Combined Corporate Presentation,' indicating a potential transaction.
- No financial details, merger agreement, or definitive terms are provided in the filing or available exhibit text.
- Filing does not include any forward-looking guidance, revenue impact, or timeline for the proposed combination.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1472012/000110465923078220/0001104659-23-078220-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1472012/000110465923078220/tm2320602d1_8k.htm
  HTML page:      https://secwatch.observer/filing/0001104659-23-078220

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer